The relative exposure of the operating room staff to sevoflurane during intracerebral surgery

Béla Tankó, Csilla Molnár, Tímea Budi, Csaba Peto, László Novák, B. Fülesdi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

BACKGROUND: Our primary aim in this study was to investigate whether escape of the volatile anesthetic sevoflurane from the surgical site during craniotomy for tumor resection increases the exposure of the neurosurgeon to the anesthetic when compared with the anesthesiologist. METHODS: Initially, the release of sevoflurane from the surgical site was measured during 35 tumorectomies starting from opening to closure of the dura. Volatile anesthetic absorbers were placed at three detection sites: 1) the surgeon's breathing zone, 2) the anesthesiologist's breathing zone, and 3) the farthest corner of the operation room. In the second sampling series that included 16 patients, the detector that had been in the corner of the operating room in the first series was now placed in the vicinity of the patient's mouth (within 5 cm). Sevoflurane captured by the absorbers was quantified by an independent chemist using chromatography. RESULTS: Absorbers in the surgeon's breathing zone (0.24 ± 0.04 ppm) captured a significantly lower amount of sevoflurane compared with absorbers in the anesthesiologist's breathing zone (1.40 ± 0.37 ppm) and comparable with that in the farthest corner of the operation room (0.25 ± 0.07 ppm). There was no correlation between the amount of absorbed sevoflurane and the size of craniotomy window, even when adjusting for the variation in duration of surgery. In the second series of sampling, absorbers in the proximity of the patient's mouth captured the highest amount of sevoflurane (1.54 ± 0.55 ppm), followed by the anesthesiologist's (1.14 ± 0.43 ppm) and the surgeon's (0.15 ± 0.05 ppm) breathing zones. CONCLUSIONS: The close proximity of the surgeon's breathing zone to the craniotomy window does not appear to be a source of increased exposure to sevoflurane. The observed higher exposure of the anesthesiologist to sevoflurane in the operating room environment warrants further exploration.

Original languageEnglish
Pages (from-to)1187-1192
Number of pages6
JournalAnesthesia and Analgesia
Volume109
Issue number4
DOIs
Publication statusPublished - Oct 2009

Fingerprint

Operating Rooms
Respiration
Craniotomy
Anesthetics
Mouth
sevoflurane
Chromatography
Anesthesiologists
Surgeons

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The relative exposure of the operating room staff to sevoflurane during intracerebral surgery. / Tankó, Béla; Molnár, Csilla; Budi, Tímea; Peto, Csaba; Novák, László; Fülesdi, B.

In: Anesthesia and Analgesia, Vol. 109, No. 4, 10.2009, p. 1187-1192.

Research output: Contribution to journalArticle

Tankó, Béla ; Molnár, Csilla ; Budi, Tímea ; Peto, Csaba ; Novák, László ; Fülesdi, B. / The relative exposure of the operating room staff to sevoflurane during intracerebral surgery. In: Anesthesia and Analgesia. 2009 ; Vol. 109, No. 4. pp. 1187-1192.
@article{1996070ab4154049b25482a442913a99,
title = "The relative exposure of the operating room staff to sevoflurane during intracerebral surgery",
abstract = "BACKGROUND: Our primary aim in this study was to investigate whether escape of the volatile anesthetic sevoflurane from the surgical site during craniotomy for tumor resection increases the exposure of the neurosurgeon to the anesthetic when compared with the anesthesiologist. METHODS: Initially, the release of sevoflurane from the surgical site was measured during 35 tumorectomies starting from opening to closure of the dura. Volatile anesthetic absorbers were placed at three detection sites: 1) the surgeon's breathing zone, 2) the anesthesiologist's breathing zone, and 3) the farthest corner of the operation room. In the second sampling series that included 16 patients, the detector that had been in the corner of the operating room in the first series was now placed in the vicinity of the patient's mouth (within 5 cm). Sevoflurane captured by the absorbers was quantified by an independent chemist using chromatography. RESULTS: Absorbers in the surgeon's breathing zone (0.24 ± 0.04 ppm) captured a significantly lower amount of sevoflurane compared with absorbers in the anesthesiologist's breathing zone (1.40 ± 0.37 ppm) and comparable with that in the farthest corner of the operation room (0.25 ± 0.07 ppm). There was no correlation between the amount of absorbed sevoflurane and the size of craniotomy window, even when adjusting for the variation in duration of surgery. In the second series of sampling, absorbers in the proximity of the patient's mouth captured the highest amount of sevoflurane (1.54 ± 0.55 ppm), followed by the anesthesiologist's (1.14 ± 0.43 ppm) and the surgeon's (0.15 ± 0.05 ppm) breathing zones. CONCLUSIONS: The close proximity of the surgeon's breathing zone to the craniotomy window does not appear to be a source of increased exposure to sevoflurane. The observed higher exposure of the anesthesiologist to sevoflurane in the operating room environment warrants further exploration.",
author = "B{\'e}la Tank{\'o} and Csilla Moln{\'a}r and T{\'i}mea Budi and Csaba Peto and L{\'a}szl{\'o} Nov{\'a}k and B. F{\"u}lesdi",
year = "2009",
month = "10",
doi = "10.1213/ane.0b013e3181b0cbea",
language = "English",
volume = "109",
pages = "1187--1192",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The relative exposure of the operating room staff to sevoflurane during intracerebral surgery

AU - Tankó, Béla

AU - Molnár, Csilla

AU - Budi, Tímea

AU - Peto, Csaba

AU - Novák, László

AU - Fülesdi, B.

PY - 2009/10

Y1 - 2009/10

N2 - BACKGROUND: Our primary aim in this study was to investigate whether escape of the volatile anesthetic sevoflurane from the surgical site during craniotomy for tumor resection increases the exposure of the neurosurgeon to the anesthetic when compared with the anesthesiologist. METHODS: Initially, the release of sevoflurane from the surgical site was measured during 35 tumorectomies starting from opening to closure of the dura. Volatile anesthetic absorbers were placed at three detection sites: 1) the surgeon's breathing zone, 2) the anesthesiologist's breathing zone, and 3) the farthest corner of the operation room. In the second sampling series that included 16 patients, the detector that had been in the corner of the operating room in the first series was now placed in the vicinity of the patient's mouth (within 5 cm). Sevoflurane captured by the absorbers was quantified by an independent chemist using chromatography. RESULTS: Absorbers in the surgeon's breathing zone (0.24 ± 0.04 ppm) captured a significantly lower amount of sevoflurane compared with absorbers in the anesthesiologist's breathing zone (1.40 ± 0.37 ppm) and comparable with that in the farthest corner of the operation room (0.25 ± 0.07 ppm). There was no correlation between the amount of absorbed sevoflurane and the size of craniotomy window, even when adjusting for the variation in duration of surgery. In the second series of sampling, absorbers in the proximity of the patient's mouth captured the highest amount of sevoflurane (1.54 ± 0.55 ppm), followed by the anesthesiologist's (1.14 ± 0.43 ppm) and the surgeon's (0.15 ± 0.05 ppm) breathing zones. CONCLUSIONS: The close proximity of the surgeon's breathing zone to the craniotomy window does not appear to be a source of increased exposure to sevoflurane. The observed higher exposure of the anesthesiologist to sevoflurane in the operating room environment warrants further exploration.

AB - BACKGROUND: Our primary aim in this study was to investigate whether escape of the volatile anesthetic sevoflurane from the surgical site during craniotomy for tumor resection increases the exposure of the neurosurgeon to the anesthetic when compared with the anesthesiologist. METHODS: Initially, the release of sevoflurane from the surgical site was measured during 35 tumorectomies starting from opening to closure of the dura. Volatile anesthetic absorbers were placed at three detection sites: 1) the surgeon's breathing zone, 2) the anesthesiologist's breathing zone, and 3) the farthest corner of the operation room. In the second sampling series that included 16 patients, the detector that had been in the corner of the operating room in the first series was now placed in the vicinity of the patient's mouth (within 5 cm). Sevoflurane captured by the absorbers was quantified by an independent chemist using chromatography. RESULTS: Absorbers in the surgeon's breathing zone (0.24 ± 0.04 ppm) captured a significantly lower amount of sevoflurane compared with absorbers in the anesthesiologist's breathing zone (1.40 ± 0.37 ppm) and comparable with that in the farthest corner of the operation room (0.25 ± 0.07 ppm). There was no correlation between the amount of absorbed sevoflurane and the size of craniotomy window, even when adjusting for the variation in duration of surgery. In the second series of sampling, absorbers in the proximity of the patient's mouth captured the highest amount of sevoflurane (1.54 ± 0.55 ppm), followed by the anesthesiologist's (1.14 ± 0.43 ppm) and the surgeon's (0.15 ± 0.05 ppm) breathing zones. CONCLUSIONS: The close proximity of the surgeon's breathing zone to the craniotomy window does not appear to be a source of increased exposure to sevoflurane. The observed higher exposure of the anesthesiologist to sevoflurane in the operating room environment warrants further exploration.

UR - http://www.scopus.com/inward/record.url?scp=70349573492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349573492&partnerID=8YFLogxK

U2 - 10.1213/ane.0b013e3181b0cbea

DO - 10.1213/ane.0b013e3181b0cbea

M3 - Article

VL - 109

SP - 1187

EP - 1192

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 4

ER -